Literature DB >> 33556098

Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis.

Lluís Revilla1,2, Aida Mayorgas2, Ana M Corraliza2, Maria C Masamunt2, Amira Metwaly3, Dirk Haller3,4, Eva Tristán1,5, Anna Carrasco1,5, Maria Esteve1,5, Julian Panés1,2, Elena Ricart1,2, Juan J Lozano1, Azucena Salas2.   

Abstract

BACKGROUND: Personalized medicine requires finding relationships between variables that influence a patient's phenotype and predicting an outcome. Sparse generalized canonical correlation analysis identifies relationships between different groups of variables. This method requires establishing a model of the expected interaction between those variables. Describing these interactions is challenging when the relationship is unknown or when there is no pre-established hypothesis. Thus, our aim was to develop a method to find the relationships between microbiome and host transcriptome data and the relevant clinical variables in a complex disease, such as Crohn's disease.
RESULTS: We present here a method to identify interactions based on canonical correlation analysis. We show that the model is the most important factor to identify relationships between blocks using a dataset of Crohn's disease patients with longitudinal sampling. First the analysis was tested in two previously published datasets: a glioma and a Crohn's disease and ulcerative colitis dataset where we describe how to select the optimum parameters. Using such parameters, we analyzed our Crohn's disease data set. We selected the model with the highest inner average variance explained to identify relationships between transcriptome, gut microbiome and clinically relevant variables. Adding the clinically relevant variables improved the average variance explained by the model compared to multiple co-inertia analysis.
CONCLUSIONS: The methodology described herein provides a general framework for identifying interactions between sets of omic data and clinically relevant variables. Following this method, we found genes and microorganisms that were related to each other independently of the model, while others were specific to the model used. Thus, model selection proved crucial to finding the existing relationships in multi-omics datasets.

Entities:  

Mesh:

Year:  2021        PMID: 33556098      PMCID: PMC7870068          DOI: 10.1371/journal.pone.0246367

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  46 in total

Review 1.  Dysbiotic gut microbiome: A key element of Crohn's disease.

Authors:  Styrk Furnes Øyri; Györgyi Műzes; Ferenc Sipos
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2015-10-25       Impact factor: 2.268

2.  UPARSE: highly accurate OTU sequences from microbial amplicon reads.

Authors:  Robert C Edgar
Journal:  Nat Methods       Date:  2013-08-18       Impact factor: 28.547

Review 3.  Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.

Authors:  J McIlroy; G Ianiro; I Mukhopadhya; R Hansen; G L Hold
Journal:  Aliment Pharmacol Ther       Date:  2017-10-16       Impact factor: 8.171

4.  A framework for human microbiome research.

Authors: 
Journal:  Nature       Date:  2012-06-13       Impact factor: 49.962

5.  Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies.

Authors:  Anna Klindworth; Elmar Pruesse; Timmy Schweer; Jörg Peplies; Christian Quast; Matthias Horn; Frank Oliver Glöckner
Journal:  Nucleic Acids Res       Date:  2012-08-28       Impact factor: 16.971

6.  Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas.

Authors:  Stephanie Puget; Cathy Philippe; Dorine A Bax; Bastien Job; Pascale Varlet; Marie-Pierre Junier; Felipe Andreiuolo; Dina Carvalho; Ricardo Reis; Lea Guerrini-Rousseau; Thomas Roujeau; Philippe Dessen; Catherine Richon; Vladimir Lazar; Gwenael Le Teuff; Christian Sainte-Rose; Birgit Geoerger; Gilles Vassal; Chris Jones; Jacques Grill
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

7.  Metagenomic biomarker discovery and explanation.

Authors:  Nicola Segata; Jacques Izard; Levi Waldron; Dirk Gevers; Larisa Miropolsky; Wendy S Garrett; Curtis Huttenhower
Journal:  Genome Biol       Date:  2011-06-24       Impact factor: 13.583

8.  mixOmics: An R package for 'omics feature selection and multiple data integration.

Authors:  Florian Rohart; Benoît Gautier; Amrit Singh; Kim-Anh Lê Cao
Journal:  PLoS Comput Biol       Date:  2017-11-03       Impact factor: 4.475

Review 9.  Microbiome evolution during host aging.

Authors:  Francisco Daniel Davila Aleman; Dario Riccardo Valenzano
Journal:  PLoS Pathog       Date:  2019-07-25       Impact factor: 6.823

10.  Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects.

Authors:  Mireia Lopez-Siles; Núria Enrich-Capó; Xavier Aldeguer; Miriam Sabat-Mir; Sylvia H Duncan; L Jesús Garcia-Gil; Margarita Martinez-Medina
Journal:  Front Cell Infect Microbiol       Date:  2018-09-07       Impact factor: 5.293

View more
  3 in total

1.  Inflammatory Bowel Disease Therapy: Beyond the Immunome.

Authors:  Claudio Fiocchi; Dimitrios Iliopoulos
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

2.  Location-specific signatures of Crohn's disease at a multi-omics scale.

Authors:  Carlos G Gonzalez; Robert H Mills; Qiyun Zhu; Consuelo Sauceda; Rob Knight; Parambir S Dulai; David J Gonzalez
Journal:  Microbiome       Date:  2022-08-24       Impact factor: 16.837

3.  Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All.

Authors:  Padhmanand Sudhakar; Dahham Alsoud; Judith Wellens; Sare Verstockt; Kaline Arnauts; Bram Verstockt; Severine Vermeire
Journal:  J Crohns Colitis       Date:  2022-08-30       Impact factor: 10.020

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.